Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.98
1.89%
After-hours: Aug 15, 2025, 04:13 PM EDT
14.24%
Bid 0.93
Market Cap 68.61M
Revenue (ttm) 548K
Net Income (ttm) -24.97M
EPS (ttm) -0.54
PE Ratio (ttm) -1.79
Forward PE -0.8
Analyst Buy
Ask 1
Volume 4,404,812
Avg. Volume (20D) 1,740,862
Open 0.86
Previous Close 0.84
Day's Range 0.81 - 1.02
52-Week Range 0.24 - 1.47
Beta 0.21

About OVID

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OVID
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OVID stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Ovid Therapeutics has released their quartely earnings on Aug 13, 2025:
  • Revenue of $6.27M exceeds estimates by $6.16M, with 3611.24% YoY growth.
  • EPS of -0.06 exceeds estimates by 0.09, with -150.00% YoY decline.
  • Next Earnings Release

    Ovid Therapeutics Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 days ago
    +56.86%
    Ovid Therapeutics shares are trading higher after ... Unlock content with Pro Subscription
    3 months ago
    +3.11%
    Ovid Therapeutics shares are trading higher after the company reported better-than-expected Q1 sales results.